SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $27,359,172 | 1.46% |
| Samsara BioCapital, LLC | 1,675,579 | $7,791,442 | 1.37% |
| Kynam Capital Management, LP | 1,500,000 | $6,975,000 | 0.96% |
| Parkman Healthcare Partners LLC | 1,143,861 | $5,318,954 | 0.92% |
| Rubric Capital Management LP | 4,048,744 | $18,826,660 | 0.80% |
| BVF INC/IL | 3,347,946 | $15,567,949 | 0.43% |
| Opaleye Management Inc. | 307,000 | $1,427,550 | 0.34% |
| SECTORAL ASSET MANAGEMENT INC | 400,646 | $1,863,004 | 0.31% |
| DAFNA Capital Management LLC | 242,779 | $1,128,922 | 0.31% |
| Eversept Partners, LP | 747,912 | $3,477,791 | 0.29% |
| Frazier Life Sciences Management, L.P. | 780,000 | $3,627,000 | 0.22% |
| Tejara Capital Ltd | 88,682 | $412,371 | 0.20% |
| Virtus Fund Advisers, LLC | 4,412 | $20,516 | 0.14% |
| Verition Fund Management LLC | 1,946,660 | $9,051,969 | 0.12% |
| Virtus Investment Advisers, Inc. | 28,274 | $131,474 | 0.09% |
| Simplify Asset Management Inc. | 120,000 | $558,000 | 0.07% |
| Candriam S.C.A. | 1,628,234 | $7,571,288 | 0.06% |
| Holocene Advisors, LP | 2,132,873 | $9,917,859 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 36,163 | $168,158 | 0.03% |
| Tekla Capital Management LLC | 98,354 | $457,346 | 0.02% |
External links
This page lists SUTRO BIOPHARMA INC's shareholders in Q2 2023. To view SUTRO BIOPHARMA INC's shareholder history, click here.